U.S. market Closed. Opens in 1 hour 43 minutes

MRK | Merck & Co., Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for MRK we got that it has strong fundamentals where Valuation is considered to be significantly undervalued, Profitability is very wealthy, Growth is very good and Health is strong.

Valuation (81%)

Company Industry
P/E Ratio (TTM) 19.14 47.53
PEG Ratio (TTM) 0.04 2.49
P/S Ratio (TTM) 4.21 8.63
P/B Ratio (TTM) 6.03 24.62
P/FCF Ratio (TTM) 20.00 -43.64
Price to 5YR AVG Earnings Ratio 29.36 58.85
Price to 5YR AVG FCF Ratio 26.80 88.41

Profitability (75%)

Company Industry
ROA (TTM) 12.20% 6.56%
ROE (TTM) 33.76% 31.22%
Net Profit Margin (TTM) 21.97% 13.37%
ROIC 5YR AVG 18.22% 20.64%

Growth (77%)

4QTR AVG 3YR AVG 5YR AVG
EPS 139.98% 39.20% 6.22%
Revenue 2.02% 5.57% 7.96%
Net Income 139.14% 38.23% 5.69%
Cash Flow 312.51% 12.32% 8.08%

Health (68%)

Company Industry
Current Ratio (TTM) 1.47 1.11
Quick Ratio (TTM) 1.22 0.88
D/E Ratio (TTM) 0.87 3.19
Interest Coverage (TTM) 13.76 15.05
Piotroski F-Score 6 6
Altman Z-Score 4.20 4.79
LTL to 5YR AVG FCF 3.43 4.05
Shares Outstanding Growth 5YR AVG -0.43% 1.14%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙